SpyGlass Pharma SGP
NASDAQ SGP
$28.94 -0.05 (-0.17%)
As of: Sep 4, 2026 · 3:59 PM EDT

SpyGlass Pharma (SGP) Interest & Investment Income (2025 - 2026)

Analysis

SpyGlass Pharma (SGP) Interest & Investment Income (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 35.58 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 5.13 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 10.98 Mn
10 SpyGlass Pharma 973.76 Mn 973.76 Mn - 2.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.10 Mn
Jun 30, 2025 622,000.00